A new strategy for prevention of anastomotic stricture using tacrolimus-eluting biodegradable nanofiber

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 3, 2009, Pages 703-709

  Mutsuga, Masato ^a   Narita, Yuji ^a,b   Yamawaki, Aika ^b   Satake, Makoto ^c   Kaneko, Hiroaki ^c   Suematsu, Yoshihiro ^d   Usui, Akihiko ^a   Ueda, Yuichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEIJIN LTD   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; POLYGLACTIN; SMOOTH MUSCLE ACTIN; TACROLIMUS;

ABDOMINAL AORTIC ANASTOMOSIS; ANASTOMOSIS DEHISCENCE; ANASTOMOTIC STRICTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RELEASE; END TO END ANASTOMOSIS; ENDOTHELIUM CELL; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANASTOMOSIS, SURGICAL; ANIMALS; AORTA, ABDOMINAL; AORTIC DISEASES; BIOCOMPATIBLE MATERIALS; CONSTRICTION, PATHOLOGIC; MODELS, ANIMAL; NANOSTRUCTURES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; TACROLIMUS;

EID: 60949113343     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.11.017     Document Type: Article

References (27)

1. Ogus T.N., Basaran M., Selimoglu O., Yildirim T., Ogus H., and Ozcan H. Long-term results of the left anterior descending coronary artery reconstruction with left internal thoracic artery. Ann Thorac Surg 83 (2007) 496-501
2. Souza D.S., Johansson B., Bojö L., Karlsson R., Geijer H., Filbey D., et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 132 (2007) 373-378
3. Mack M.J., Osborne J.A., and Shennib H. Arterial graft patency in coronary artery bypass grafting: what do we really know?. Ann Thorac Surg 66 (1998) 1055-1059
4. Roy-Chaudhury P., Kelly B.S., Zhang J., Narayana A., Desai P., Melham M., et al. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 21 (2003) 99-110
5. Kapadia M.R., Popowich D.A., and Kibbe M.R. Modified prosthetic vascular conduits. Circulation 117 (2008) 1873-1882
6. Hosono M., Ueda M., Suehiro S., Suehiro S., Sasaki Y., Shibata T., et al. Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J Thorac Cardiovasc Surg 120 (2000) 319-328
7. Hannan E.L., Wu C., Walford G., Culliford A.T., Gold J.P., Smith C.R., et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
8. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
9. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
10. Bartorelli A.L., Trabattoni D., Fabbiocchi F., Montorsi P., de Martini S., Calligaris G., et al. Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent. J Interv Cardiol 16 (2003) 499-505
11. Signore P.E., Machan L.S., Jackson J.K., Burt H., Bromley P., Wilson J.E., et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol 12 (2001) 79-88
12. Kawatsu S., Oda K., Saiki Y., Tabata Y., and Tabayashi K. External application of rapamycin-eluting film at anastomotic sites inhibits neointimal hyperplasia in a canine model. Ann Thorac Surg 84 (2007) 560-567
13. Kelly B., Melhem M., Zhang J., Kasting G., Li J., Krishnamoorthy M., et al. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant 21 (2006) 2425-2431
14. Schachner T., Zou Y., Oberhuber A., Tzankov A., Mairinger T., Laufer G., et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77 (2004) 1580-1585
15. Wallemacq P.E., and Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 39 (1993) 2219-2228
16. Wiederrecht G., Lam E., Hung S., Martin M., and Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 30 (1993) 9-19
17. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
18. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
19. Poon M., Marx S.O., Gallo R., Badimon J.J., Taubman M.B., and Marks A.R. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98 (1996) 2277-2283
20. Gallo R., Padurean A., Jayaraman T., Marx S., Roque M., and Adelman S. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99 (1999) 2164-2170
21. Finn A.V., Joner M., Nakazawa G., Kolodgie F., Newell J., John M.C., et al. Pathological correlates of late drug-eluting stent thrombosis strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
22. Hofma S.H., van der Giessen W.J., van Dalen B.M., Lemos P.A., McFadden E.P., Sianos G., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
23. Matter C.M., Rozenberg I., Jaschko A., Greutert H., Kurz D.J., Wnendt S., et al. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 48 (2006) 286-292
24. Fukuda D., Sata M., Tanaka K., and Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 111 (2005) 926-931
25. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
26. Shi Y., O'Brien Jr. J.E., Ala-Kokko L., Chung W., Mannion J.D., and Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Circulation 95 (1997) 997-1006
27. Shi Y., Pieniek M., Fard A., O'Brien J., Mannion J.D., and Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 93 (1996) 340-348